X
ViiV hails data showing switch from Truvada to two-drug HIV regimen
https://pharmaphorum.com/news/viiv-hails-data-showing-switch-from-truvada-to-two-drug-hiv-regimen/
ViiV
GSK’s blockbuster HIV drug linked with birth defects
Regulators issue warning after preliminary study findings
Stop obsessing about generic Advair, says GSK’s Witty
Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.